Ms Naheed Ismaili Misfeldt

KANDO id: 19186

Bio

Ms Ismaili Misfeldt joined Aberdare Ventures from Bay City Capital, a leading life sciences merchant bank. At Bay City Capital, she evaluated numerous investment opportunities in biopharmaceuticals and assisted portfolio companies in their fundraising activities. Prior to Bay City Capital, Ms Ismaili Misfeldt served as an Associate in the Healthcare Group at Chase H&Q, where she was involved in numerous advisory and capital raising activities for the bank's publicly traded and privately held clients. Since joining Aberdare in early 2003, Ms Ismaili Misfeldt has played an instrumental role in a number of new investments. These include Visionary Therapeutics, where she is a board member, as well as Conatus Pharmaceuticals, BioVerdant, Avera Pharmaceuticals, Mpex Pharmaceuticals and Ruxton Pharmaceuticals, where she has board observer responsibilities. Ms Ismaili Misfeldt received her BA from UC Berkeley and her MPH from Columbia University. She is also a graduate of the Kauffman Fellows Program, Class 9.


Career


Aberdare Ventures

Focuses on biopharmaceutical product companies.
Email: [email protected]

Education